The discovery of nitric oxide and its role in vascular biology

British Journal of Pharmacology

Volumn 147, Issue SUPPL. 1, 2006, Pages

  Moncada, S ^a   Higgs, E A ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Blood pressure; Endothelial dysfunction; Free radicals; L arginine; Mitochondria; Nitric oxide

Indexed keywords

ARGININE; FREE RADICAL; GW 273629; N(G) METHYLARGININE; NEUROTRANSMITTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; S [2 (1 IMINOETHYLAMINO)ETHYL]HOMOCYSTEINE; UNCLASSIFIED DRUG;

BIOLOGY; BLOOD VESSEL TONE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CELL DEATH; CELL METABOLISM; CELL PROLIFERATION; CELL RESPIRATION; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM; ENDOTHELIUM; HYPERTENSION; HYPOTENSION; IMMUNOLOGY; MEDICAL RESEARCH; MITOCHONDRION; MOLECULAR WEIGHT; NEUROTRANSMISSION; PATHOPHYSIOLOGY; PERIPHERAL NERVOUS SYSTEM; PHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SMOOTH MUSCLE FIBER; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; VASODILATATION;

ANIMALS; ARGININE; BLOOD VESSELS; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; FREE RADICALS; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MITOCHONDRIA; NITRIC OXIDE;

EID: 30444439216     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706458     Document Type: Review

References (41)

1. ALDERTON, W.K., ANGELL, A.D.R., CRAIG, C., DAWSON, J., GARVEY, E., MONCADA, S., MONKHOUSE, J., REES, D., RUSSELL, L.J., RUSSELL, R.J., SCHWARTZ, S., WASLIDGE, N. & KNOWLES, R.G. (2005). GW274150 and GW273629 are potent and highly selective inhibitors of inducible nitric oxide synthase in vitro and in vivo. Br. J. Pharmacol., 145, 301-312.
2. ALMEIDA, A., MONCADA, S. & BOLANOS, J.P. (2004). Nitric oxide switches on glycolysis through the AMP protein kinase and 6-phosphofructo-2- kinase pathway. Nature Cell Biol., 6, 45-51.
3. AZUMA, H., ISHIKAWA, M. & SEKIZAKI, S. (1986). Endothelium-dependent inhibition of platelet aggregation. Br. J. Pharmacol., 88, 411-415.
4. CAI, H. & HARRISON, D.O. (2000). Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ. Res., 87, 840-844.
5. CELLEK, S. (1997). Nitrergic and noradrenergic interaction in dually innervated organs of the genitourinary tract. PhD Thesis. University of London.
6. CELLEK, S. & MONCADA, S. (1997). Nitrergic modulation of cholinergic responses in the opossum lower oesophageal sphincter. Br. J. Pharmacol., 122, 1043-1046.
7. CELLEK, S., RODRIGO, J., LOBOS, E., FERNANDEZ, P., SERRANO, J. & MONCADA, S. (1999). Selective nitrergic neurodegeneration in diabetes mellitus - a nitric oxide-dependent phenomenon. Br. J. Pharmacol., 128, 1804-1812.
8. FLEMING, I. & BUSSE, R. (2004). The physiology of nitric oxide: control and consequences. Curr. Med. Chem., 3, 189-205.
9. FURCHGOTT, R.F. (1988). Studies on relaxation of rabbit aorta by sodium nitrite: the basis for the proposal that the acid-activatable inhibitory factor from retractor penis is inorganic nitrite and the endothelium-derived relaxing factor is nitric oxide. In: Vasodilatation: Vascular Smooth Muscle, Peptides, Autonomic Nerves and Endothelium, ed. Vanhoutte, P.M., pp. 401-414. New York: Raven Press.
10. FURCHGOTT, R.F. & ZAWADZKI, J.V. (1980). The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature, 288, 373-376.
11. FURCHGOTT, R.F., CHERRY, P.D., ZAWADZKI, J.V. & JOTHIANANDAN, D. (1984). Endothelial cells as mediators of vasodilation of arteries. J. Cardiovasc. Pharmacol., 6, S336-S343.
12. GREENACRE, S.A. & ISCHIROPOULOS, H. (2001). Tyrosine nitration: localisation, quantification, consequences for protein function and signal transduction. Free Radic. Res., 34, 541-581.
13. GRYGLEWSKI, R.J., MONCADA, S. & PALMER, R.M.I. (1986a). Bioassay of prostacyclin and endothelium-derived relaxing factor (EDRF) from porcine aortic endothelial cells. Br. J. Pharmacol., 87, 685-694.
14. GRYGLEWSKI, R.J., PALMER, R.M.J. & MONCADA, S. (1986b). Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature, 320, 454-456.
15. HAGEN, T., TAYLOR, C.T., LAM, F. & MONCADA, S. (2003). Redistribution of intracellular oxygen in hypoxia by nitric oxide: effect on HIF1α. Science, 302, 1975-1978.
16. HIBBS Jr, J.B., TAINTOR, R.R. & VAVRIN, Z. (1987). Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science, 235, 473-476.
17. HUANG, P.L. (2000). Lessons learned from nitric oxide synthase knockout animals. Semin. Perinatol., 24, 87-90.
18. IGNARRO, L.J., BYRNS, R.E. & WOOD, K.S. (1988). Biochemical and pharmacological properties of endothelium-derived relaxing factor and its similarity to nitric oxide radical. In: Vasodilatation: Vascular Smooth Muscle, Peptide, Autonomic Nerves and Endothelium, ed. Vanhoutte, P.M., pp. 427-436. New York: Raven Press.
19. IYENGAR, R., STUEHR, D.J. & MARLETTA, M.A. (1987). Macrophage synthesis of nitrite, nitrate and N-nitrosamines: precursors and role of the respiratory burst. Proc. Natl. Acad. Sci. U.S.A., 84, 6369-6373.
20. KHALIL, R.A. (2005). Sex hormones as potential modulators of vascular function in hypertension. Hypertension, 46, 249-254.
21. LASZLO, F., WHITTLE, B.J.R. & MONCADA, S. (1994). Time-dependent enhancement or inhibition of endotoxin-induced vascular injury in rat intestine by nitric oxide synthase inhibitors. Br. J. Pharmacol., 111, 1309-1315.
22. LAUFS, U. (2003). Beyond lipid-lowering: effects of statins on endothelial nitric oxide. Eur. J. Clin. Pharmacol., 58, 719-731.
23. LIN, M.I., FULTON, D., BABBITT, R., FLEMING, I., BUSSE, R., PRITCHARD Jr, K.A. & SESSA, W.C. (2003). Phosphorylation of threonine 497 in endothelial nitric-oxide synthase coordinates the coupling of L-arginine metabolism to efficient nitric oxide production. J. Biol. Chem., 278, 44719-44726.
24. LOPEZ, A., LORENTE, J.A., STEINGRUB, J., BAKKER, J., MCLUCKIE, A., WILLATTS, S., BROCKWAY, M., ANZUETO, A., HOLZAPFEL, L., BREEN, D., SILVERMAN, M.S., TAKALA, J., DONALDSON, J., ARNESON, C., GROVE, G., GROSSMAN, S. & GROVER, R. (2004). Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit. Care Med., 32, 21-30.
25. MONCADA, S. (2005). Adventures in vascular biology: a tale of two mediators. Phil. Trans. Roy. Soc. B., in press.
26. MONCADA, S. & ERUSALIMSKY, J.D. (2002). Does nitric oxide modulate mitochondrial energy generation and apoptosis? Nat. Rev. Mol. Cell Biol., 3, 214-220.
27. MONCADA, S. & HIGGS, E.A. (2000). Nitric oxide in cardiovascular function and disease. In: Atherosclerosis XII, Proceedings of the XIIth International Symposium on Atherosclerosis, eds. Stemme, S. & Olsson, A.G., pp. 81-89. Stockholm, The Netherlands: Elsevier.
28. MONCADA, S., PALMER, R.M.J. & GRYGLEWSKI, R.J. (1986). Mechanism of action of some inhibitors of endothelium-derived relaxing factor. Proc. Natl. Acad. Sci. U.S.A., 83, 9164-9168.
29. MONCADA, S., PALMER, R.M.J. & HIGGS, E.A. (1989). Biosynthesis of nitric oxide from L-arginine. A pathway for the regulation of cell function and communication. Biochem. Pharmacol., 38, 1709-1715.
30. NISOLI, E., CLEMENTI, E., PAOLUCCI, C., COZZI, V., TONELLO, C., SCIORATI, C., BRACALE, R., VALERIO, A., FRANCOLINI, M., MONCADA, S. & CARRUBA, M.O. (2003). Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science, 299, 896-899.
31. PALACIOS-CALLENDER, M., QUINTERO, M., HOLLIS, V.S., SPRINGETT, R.J. & MONCADA, S. (2004). Endogenous NO regulates superoxide production at low oxygen concentrations by modifying the redox state of cytochrome c oxidase. Proc. Natl. Acad. Sci. U.S.A., 101, 7630-7635.
32. PALMER, R.M.J., FERRIGE, A.G. & MONCADA, S. (1987). Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature, 327, 524-526.
33. PALMER, R.M.J., ASHTON, D.S. & MONCADA, S. (1988). Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature, 333, 664-666.
34. RADOMSKI, M.W., PALMER, R.M.J. & MONCADA, S. (1987). The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br. J.Pharmacol., 92, 639-646.
35. REES, D.D., PALMER, R.M.J., HUDSON, H.F. & MONCADA, S. (1989a). A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br. J. Pharmacol., 96, 418-424.
36. REES, D.D., PALMER, R.M.J. & MONCADA, S. (1989b). Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc. Natl. Acad. Sci. U.S.A., 86, 3375-3378.
37. REES, D.D., HIGGS, E.A. & MONCADA, S. (2000). Nitric oxide and the vessel wall. In: Hemostasis and Thrombosis, eds. Colman, R.W., Hirsch, J., Marder, V.J., Clowes, A.W. & George, N.J., pp. 673-682. Lippincott Williams & Wilkins: Philadelphia.
38. 2+-independent nitric oxide synthase in the myocardium. Br. J Pharmacol., 105, 575-580.
39. SCOTLAND, R.S., MADHANI, M., CHAUHAN, S., MONCADA, S., ANDRESEN, J., NILSSON, H., HOBBS, A.J. & AHLUWALIA, A. (2005). Investigation of vascular responses in endothelial nitric oxide synthase/cyclooxygenase-1 double-knockout mice. Key role for endothelium-derived hyperpolarizing factor in the regulation of blood pressure in vivo. Circulation, 111, 796-803.
40. WEINER, C.P., LIZASOAIN, I., BAYLIS, S.A., KNOWLES, R.G., CHARLES, I.G. & MONCADA, S. (1994). Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc. Natl. Acad. Sci. U.S.A., 91, 5212-5216.
41. XU, W., CHARLES, I.G. & MONCADA, S. (2005). Nitric oxide: orchestrating hypoxia regulation through mitochondrial respiration and the endoplasmic reticulum stress response. Cell Res., 15, 63-65.